원저 : 간문맥 혈전이 동반된 진행성 간세포암에서의 동시 항암 화학 - 방사선요법 ( Original Articles : Concurrent Chemo - Radiation Therapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis ) |
|
|
Concurrent Chemo - Radiation Therapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis |
Jin Suk Kim, M.D., Kwang-Hyub Han, M.D., Do Yun Lee, M.D.* , Jin-Sil Seong, M.D.† ,
Young Hoon Youn, M.D., Jae Youn Cheong, M.D., Sang Hoon Ahn, M.D.,
Chae Yoon Chon, M.D., and Young Myoung Moon, M.D. |
Departments of Internal Medicine, Diagnostic Radiology *, and Radiation Oncology †, Yonsei University College of Medicine, Seoul, Korea |
|
|
ABSTRACT |
|
Background/Aims Advanced hepatocellular carcinoma with portal vein thrombosis has a poor prognosis. This study was undertaken to evaluate the therapeutic effects of concurrent chemo-radiation therapy in advanced hepatocellular carcinoma with portal vein thrombosis. Methods: A total of 54 patients with advanced hepatocellular carcinoma (TNM stage IVa) were enrolled. Nineteen patients were treated with external beam radiotherapy (4,500 cGy/ 5 weeks) and intrahepatic arterial 5-FU infusion (500 mg on 1-5 day and 30-35 day, respectively) via implanted chemoport. The others were treated with intrahepatic arterial cisplatin infusion (80 mg/m2). Results: In patients treated with concurrent chemo-radiation therapy, response rates at 2nd and 6th months were 42.1% and 26.3%, respectively. In patients treated with intrahepatic arterial cisplatin therapy, response rates at 2nd and 6th months were 2.9% and 0%, respectively. The median survival time was 11.6 months in concurrent chemo-radiation therapy and 4.8 months in intrahepatic arterial cisplatin infusion therapy. Concurrent chemo-radiation therapy produced better response rates and longer survival time than those of intrahepatic arterial cisplatin infusion therapy (p<0.05). Conclusions: Concurrent chemo-radiation therapy achieved favorable results in advanced hepatocellular carcinoma with portal vein thrombosis and can be considered as a treatment option for the management of advanced hepatocellular carcinoma.(Korean J Hepatol 2002;8:71-79) |
KeyWords:
Neoplasm/ Liver/Hepatocellular carcinoma, Portal vein thrombosis , Chemo- radiation therapy Cisplatin |
|
|